Follow
Stijn de Vos
Title
Cited by
Cited by
Year
Can we jump from cross-sectional to dynamic interpretations of networks implications for the network perspective in psychiatry
FM Bos, E Snippe, S De Vos, JA Hartmann, CJP Simons, ...
Psychotherapy and psychosomatics 86 (3), 175-177, 2017
1622017
HowNutsAreTheDutch (HoeGekIsNL): A crowdsourcing study of mental symptoms and strengths
LVD Krieke, BF Jeronimus, FJ Blaauw, RBK Wanders, AC Emerencia, ...
International journal of methods in psychiatric research 25 (2), 123-144, 2016
1452016
A transdiagnostic network approach to psychosis
JTW Wigman, S de Vos, M Wichers, J van Os, AA Bartels-Velthuis
Schizophrenia bulletin 43 (1), 122-132, 2017
1012017
An investigation of emotion dynamics in major depressive disorder patients and healthy persons using sparse longitudinal networks
S De Vos, KJ Wardenaar, EH Bos, EC Wit, MEJ Bouwmans, P De Jonge
PLoS One 12 (6), e0178586, 2017
722017
Decomposing the heterogeneity of depression at the person-, symptom-, and time-level: latent variable models versus multimode principal component analysis
S de Vos, KJ Wardenaar, EH Bos, EC Wit, P De Jonge
BMC Medical Research Methodology 15, 1-10, 2015
372015
A systematic literature review and meta‐analysis of community pharmacist‐led interventions to optimise the use of antibiotics
M Lambert, CCH Smit, S De Vos, R Benko, C Llor, WJ Paget, K Briant, ...
British journal of clinical pharmacology 88 (6), 2617-2641, 2022
232022
HowNutsAreTheDutch: personalized feedback on a national scale
F Blaauw, L van der Krieke, E Bos, A Emerencia, BF Jeronimus, ...
2014 AAAI Fall Symposium Series, 2014
172014
Sex disparities in the effect of statins on lipid parameters: The PharmLines Initiative
NB Hunt, JE Emmens, S Irawati, S de Vos, JHJ Bos, B Wilffert, E Hak, ...
Medicine 101 (2), e28394, 2022
142022
Chronic use of hydrochlorothiazide and risk of skin cancer in caucasian adults: a pharmlines initiative inception cohort study
MS Haisma, N Greven, M Logendran, J Bos, BVD Vegt, B Horváth, ...
Acta dermato-venereologica 103, adv3933, 2023
132023
Toward evidence‐based medical statistics: a Bayesian analysis of double‐blind placebo‐controlled antidepressant trials in the treatment of anxiety disorders
R Monden, S de Vos, R Morey, EJ Wagenmakers, P de Jonge, AM Roest
International Journal of Methods in Psychiatric Research 25 (4), 299-308, 2016
132016
HowNutsAreTheDutch ((HoeGekIsNL): A crowdsourcing study of mental symptoms and strengths. International Journal of Methods in Psychiatric Research, 25 (2), 123–144
L Van Der Krieke, BF Jeronimus, FJ Blaauw, RBK Wanders, ...
92016
Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis
G Zhou, S Verweij, MJ Bijlsma, S de Vos, KO Rengerink, AMG Pasmooij, ...
BMJ open respiratory research 10 (1), e001674, 2023
62023
Subtyping psychological distress in the population: a semi-parametric network approach
S de Vos, S Patten, EC Wit, EH Bos, KJ Wardenaar, P de Jonge
Epidemiology and Psychiatric Sciences 29, e36, 2020
62020
In utero antidepressant exposure not associated with ADHD in the offspring: A case control sibling design
CAM Hartwig, R Robiyanto, S de Vos, JHJ Bos, EP van Puijenbroek, ...
Frontiers in Pharmacology 13, 1000018, 2022
42022
Antidepressant use during pregnancy and development of preeclampsia: A focus on classes of action and specific transporters/receptors targeted by antidepressants
YH Tran, HK Huynh, MM Faas, S de Vos, H Groen
Journal of Psychiatric Research 146, 92-101, 2022
42022
Targeting the beta-2-adrenergic receptor and the risk of developing Alzheimer’s disease: A retrospective inception cohort study
DR Hutten, JHJ Bos, S de Vos, E Hak
Journal of Alzheimer's Disease 87 (3), 1089-1101, 2022
42022
Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus
MP Oktora, S de Vos, ST de Vries, E Hak, P Denig
Pharmacoepidemiology and Drug Safety 32 (12), 1395-1405, 2023
32023
Role of traditional cardiovascular risk factors after initiation of statin therapy: a pharmlines inception cohort study
D Steenhuis, S De Vos, J Bos, E Hak
Cardiovascular therapeutics 2022 (1), 6587165, 2022
32022
Risk factors for drug-treated major adverse cardio-cerebrovascular events in patients on primary preventive statin therapy: a retrospective cohort study
D Steenhuis, S de Vos, JHJ Bos, E Hak
Preventive Medicine Reports 34, 102258, 2023
22023
Association between adherence to statin therapy and low-density lipoprotein cholesterol (LDL-c) response in first-time users of standard-dose and low-dose statins: the …
S Irawati, JE Emmens, S de Vos, JHJ Bos, RA de Boer, E Hak
Current Medical Research and Opinion 38 (1), 1-6, 2022
22022
The system can't perform the operation now. Try again later.
Articles 1–20